Suppression of Gq function using intrapipette delivery of shRNA during extracellular recording in the ventral tegmental area

Frontiers in Cellular Neuroscience

Volumn , Issue JANUARY 2013, 2013, Pages 1-20

  Nimitvilai, Sudarat ^a   Arora, Devinder S ^a   McElvain, Maureen A ^a   Brodie, Mark S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Desensitization; Dopamine D2 receptor; Gq; Lentivirus; Neurotensin; shRNA; Ventral tegmental area

Indexed keywords

DOPAMINE; GQ PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROTENSIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MICROPIPETTE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; VENTRAL TEGMENTUM;

EID: 84872897043     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00007     Document Type: Article

References (42)

1. Borghese, C.M., Werner, D.F., Topf, N., Baron, N.V., Henderson, L.A., Boehm, S.L., Blednov, Y.A., Saad, A., Dai, S., Pearce, R.A., Harris, R.A., Homanics, G.E., Harrison, N.L. (2006). An isoflurane-and alcohol-insensitive mutant GABA(A) receptor alpha(1) subunit with near-normal apparent affinity for GABA: characterization in heterologous systems and production of knockin mice. J. Pharmacol. Exp. Ther. 319, 208-218.
2. Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.L., Iggo, R. (2003). Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264.
3. Brodie, M.S., McElvain, M.A., Bunney, E.B., Appel, S.B. (1999). Pharmacological reduction of small conductance calcium-activated potassium current (SK) potentiates the excitatory effect of ethanol on ventral tegmental area dopamine neurons. J. Pharmacol. Exp. Ther. 290, 325-333.
4. Burnett, J.C., Rossi, J.J. (2012). RNA-based therapeutics: current progress and future prospects. Chem. Biol. 19, 60-71.
5. Chieng, B., Azriel, Y., Mohammadi, S., Christie, M.J. (2011). Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J. Physiol 589, 3775-3787.
6. J.R. Cooper, F.E. Bloom, R.H. Roth (1996) "Receptors" in: The Biochemical Basis of Neuropharmacology. The Biochemical Basis of Neuropharmacology, (New York: Oxford University Press,) 83-102.
7. Davidson, B.L., Boudreau, R.L. (2007). RNA interference: a tool for querying nervous system function and an emerging therapy. Neuron 53, 781-788.
8. Farkas, R.H., Chien, P.Y., Nakajima, S., Nakajima, Y. (1997). Neurotensin and dopamine D2 activation oppositely regulate the same K+ conductance in rat midbrain dopaminergic neurons. Neurosci. Lett. 231, 21-24.
9. Gailly, P., Najimi, M., Hermans, E. (2000). Evidence for the dual coupling of the rat neurotensin receptor with pertussis toxin-sensitive and insensitive G-proteins. FEBS Lett. 483, 109-113.
10. Grace, A.A., Bunney, B.S. (1984). The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4, 2866-2876.
11. Grisshammer, R., Hermans, E. (2001). Functional coupling with Galpha(q) and Galpha(i1) protein subunits promotes high-affinity agonist binding to the neurotensin receptor NTS-1 expressed in Escherichia coli. FEBS Lett. 493, 101-105.
12. Gupta, S., Schoer, R.A., Egan, J.E., Hannon, G.J., Mittal, V. (2004). Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci.U.S. A 101, 1927-1932.
13. Halonen, L.M., Sinkkonen, S.T., Chandra, D., Homanics, G.E., Korpi, E.R. (2009). Brain regional distribution of GABA(A) receptors exhibiting atypical GABA agonism: roles of receptor subunits. Neurochem. Int. 55, 389-396.
14. Johansson, B.B., Minsaas, L., Aragay, A.M. (2005). Proteasome involvement in the degradation of the G(q) family of Galpha subunits. FEBS J. 272, 5365-5377.
15. Kalivas, P.W., Burgess, S.K., Nemeroff, C.B., Prange, A.J., Jr. (1983). Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 8, 495-505.
16. T.P. Kenakin (1987) "Analysis of dose-response data" in: Pharmacologic analysis of drugreceptor interaction. ed. T. P. Kenakin, Pharmacologic analysis of drug-receptor interaction, (New York, New York: Raven Press,) 129-162.
17. Lacey, M.G., Mercuri, N.B., North, R.A. (1989). Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids. J. Neurosci. 9, 1233-1241.
18. Mameli, M., Balland, B., Lujan, R., Luscher, C. (2007). Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science 317, 530-533.
19. Margolis, E.B., Lock, H., Hjelmstad, G.O., Fields, H.L. (2006). The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J. Physiol 577, 907-924.
20. Mitchell, F.M., Buckley, N.J., Milligan, G. (1993). Enhanced degradation of the phosphoinositidase C-linked guanine-nucleotide-binding protein Gq alpha/G11 alpha following activation of the human M1 muscarinic acetylcholine receptor expressed in CHO cells. Biochem.J. 293 (Pt 2), 495-499.
21. Mueller, A.L., Brodie, M.S. (1989). Intracellular recording from putative dopamine-containing neurons in the ventral tegmental area of Tsai in a brain slice preparation. J. Neurosci. Methods. 28, 15-22.
22. Najimi, M., Gailly, P., Maloteaux, J.M., Hermans, E. (2002). Distinct regions of C-terminus of the high affinity neurotensin receptor mediate the functional coupling with pertussis toxin sensitive and insensitive G-proteins. FEBS Lett. 512, 329-333.
23. Nimitvilai, S., Arora, D.S., Brodie, M.S. (2012a). Reversal of Dopamine Inhibition of Dopaminergic Neurons of the Ventral Tegmental Area is Mediated by Protein Kinase C. Neuropsychopharmacology 37, 543-556.
24. Nimitvilai, S., Arora, D.S., McElvain, M.A., Brodie, M.S. (2012b). Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: Interaction of GABA(B) and D2 receptors. Neuroscience 226, 29-39.
25. Nimitvilai, S., Brodie, M.S. (2010). Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area. J. Pharmacol. Exp. Ther. 333, 555-563.
26. Nimitvilai, S., McElvain, M.A., Arora, D.S., Brodie, M.S. (2012c). Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q). J. Neurophysiol. 108, 263-274.
27. Nimitvilai, S., McElvain, M.A., Brodie, M.S. (2012d). Reversal of dopamine D2 agonist-induced inhibition of ventral tegmental area neurons by Gq-linked neurotransmitters is dependent on protein kinase C, G protein-coupled receptor kinase and dynamin. J. Pharmacol. Exp. Ther.
28. Nishizuka, Y. (2001). The protein kinase C family and lipid mediators for transmembrane signaling and cell regulation. Alcohol Clin. Exp. Res. 25, 3S-7S.
29. Palacios, J.M., Kuhar, M.J. (1981). Neurotensin receptors are located on dopamine-containing neurones in rat midbrain. Nature 294, 587-589.
30. Pesavento, E., Margotti, E., Righi, M., Cattaneo, A., Domenici, L. (2000). Blocking the NGFTrkA interaction rescues the developmental loss of LTP in the rat visual cortex: role of the cholinergic system. Neuron 25, 165-175.
31. Rashid, A.J., O'Dowd, B.F., Verma, V., George, S.R. (2007a). Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends Pharmacol. Sci. 28, 551-555.
32. Rashid, A.J., So, C.H., Kong, M.M., Furtak, T., El-Ghundi, M., Cheng, R., O'Dowd, B.F., George, S.R. (2007b). D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl. Acad. Sci.U.S. A 104, 654-659.
33. Rompre, P.P., Bauco, P., Gratton, A. (1992). Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13). Eur.J. Pharmacol. 211, 295-303.
34. Sauer, B. (1998). Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392.
35. Seutin, V., Massotte, L., Dresse, A. (1989). Electrophysiological effects of neurotensin on dopaminergic neurones of the ventral tegmental area of the rat in vitro. Neuropharmacology. 28, 949-954.
36. Skrzydelski, D., Lhiaubet, A.M., Lebeau, A., Forgez, P., Yamada, M., Hermans, E., Rostene, W., Pelaprat, D. (2003). Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol. 64, 421-429.
37. Snove, O., Jr., Rossi, J.J. (2006). Chemical modifications rescue off-target effects of RNAi. ACS Chem. Biol. 1, 274-276.
38. So, C.H., Verma, V., Alijaniaram, M., Cheng, R., Rashid, A.J., O'Dowd, B.F., George, S.R. (2009). Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol. Pharmacol. 75, 843-854.
39. Steffensen, S.C., Svingos, A.L., Pickel, V.M., Henriksen, S.J. (1998). Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J. Neurosci. 18, 8003-8015.
40. Takasaki, J., Saito, T., Taniguchi, M., Kawasaki, T., Moritani, Y., Hayashi, K., Kobori, M. (2004). A novel Galphaq/11-selective inhibitor. J. Biol. Chem. 279, 47438-47445.
41. Taniguchi, M., Nagai, K., Arao, N., Kawasaki, T., Saito, T., Moritani, Y., Takasaki, J., Hayashi, K., Fujita, S., Suzuki, K., Tsukamoto, S. (2003). YM-254890, a novel platelet aggregation inhibitor produced by Chromobacterium sp. QS3666. J. Antibiot.(Tokyo) 56, 358-363.
42. Yamada, M., Yamada, M., Watson, M.A., Richelson, E. (1993). Neurotensin stimulates cyclic AMP formation in CHO-rNTR-10 cells expressing the cloned rat neurotensin receptor. Eur.J. Pharmacol. 244, 99-101.